Increased red cell corpuscular volume and hepatic mitochondrial function in NRTI-treated HIV infected patients.
An increase of the mean corpuscular volume of the red blood cells has been repeatedly described in antiretroviral treated patients. Most commonly macrocytosis was associated with the use of certain nucleoside reverse transcriptase inhibitors. The aim of this study was to analyse if macrocytosis might be a marker of mitochondrial toxicity in antiretrovirally treated HIV-infected patients. Using the (13)C-methionine breath test we analysed the hepatic mitochondrial function in vivo in antiretrovirally treated HIV-infected patients with macrocytosis. MCV was significantly negatively correlated to the breath test results. For the first time we could show a significant association between an increase of the mean corpuscular erythrocyte volume by treatment with nucleoside reverse transcriptase inhibitors (NRTI) and the hepatic mitochondrial function in vivo.
Sternfeld
Thomas
T
II. Medizinische Klinik und Poliklinik, Infektionsambulanz, Klinikum rechts der Isar, Technische Universität München, Germany. thomas.sternfeld@web.de
Lorenz
Antje
A
Schmid
Mathias
M
Schlamp
Angelika
A
Demmelmair
Hans
H
Koletzko
Berthold
B
Bogner
Johannes R
JR
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001944:Breath Tests; D002247:Carbon Isotopes / Q000378:metabolism; D048429:Cell Size; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000187:drug effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D055815:Young Adult
D019380:Anti-HIV Agents; D002247:Carbon Isotopes; D018894:Reverse Transcriptase Inhibitors